ITonis Inc. Stock Analysis ITNS
Itonis, Inc. engages in the distribution of its homeopathic anti-nausea product to the medical and pharmaceutical industry. The company is headquartered in Lake Forest, California. The company went IPO on 2007-02-21. The Company’s Pharmaceuticals division to produce and market over the counter and prescription homeopathic preparations to treat both common ailments and chronic diseases. The firm has launched the retails sale of the Emesyl nausea relief product. The firm has identified the market for its Emesyl product line as the general public who suffers from nausea. Emesyl has been available for purchase at https://www.amazon.com/dp/B00U20H3KI and www.Emesyl.com. Its subsidiaries include Itonis Holdings, Inc., Itonis Pharmaceuticals, and Paramount Discoveries, Inc.
Read More ITonis Inc (ITNS) Chart
Key Statistics of ITonis Inc (ITNS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
7887.00P/E Ratio (TTM)
-52 Week Range
Market Cap
761.71KAvg. Volume
168.54KDividend Yield
-Financial Metrics & Statements of ITonis Inc (ITNS)
FAQ's for ITonis Inc (ITNS)
- According to Musaffa’s Shariah screening methodology, ITonis Inc (ITNS) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.